As of April 15, 2025, Sanofi (SNY) has a market cap of $123.58 billion USD. According to our data, Sanofi is ranked No.125 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $123.58 B |
2.20%
|
Dec 31, 2024 | $120.92 B |
1.09%
|
Dec 29, 2023 | $119.61 B |
6.55%
|
Dec 30, 2022 | $112.26 B |
0.47%
|
Dec 31, 2021 | $111.74 B |
7.00%
|
Dec 31, 2020 | $104.43 B |
0.38%
|
Dec 31, 2019 | $104.03 B |
20.47%
|
Dec 31, 2018 | $86.35 B |
6.06%
|
Dec 29, 2017 | $81.42 B |
9.82%
|
Dec 30, 2016 | $74.14 B |
-1.19%
|
Dec 31, 2015 | $75.04 B |
-3.37%
|
Dec 31, 2014 | $77.66 B |
-11.86%
|
Dec 31, 2013 | $88.10 B |
17.11%
|
Dec 31, 2012 | $75.23 B |
35.98%
|
Dec 30, 2011 | $55.32 B |
18.86%
|
Dec 31, 2010 | $46.55 B |
-13.46%
|
Dec 31, 2009 | $53.79 B |
28.72%
|
Dec 31, 2008 | $41.79 B |
-26.49%
|
Dec 31, 2007 | $56.84 B |
1.02%
|
Dec 29, 2006 | $56.27 B |
7.24%
|
Dec 30, 2005 | $52.47 B |
11.59%
|
Dec 31, 2004 | $47.02 B |
8.24%
|
Dec 31, 2003 | $43.44 B |
26.09%
|
Dec 31, 2002 | $34.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
Market Cap | = | SNY Stock Price | * | SNY Shares Outstanding |
= | $50.60 | * | 2.44 B | |
= | $123.58 B |